Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  03:55 2022-09-28 pm EDT
3.160 USD   +1.94%
09/13Invivyd, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
09/13Invivyd, Inc. has Changed its Ticker to IVVD from ADGI
CI
09/13Adagio Therapeutics, Inc. has Changed its Name to Invivyd, Inc
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on INVIVYD, INC.
05/16Stifel Adjusts Adagio Therapeutics' Price Target to $5 From $9, Reiterates Hold Rating
MT
01/06Morgan Stanley Downgrades Adagio Therapeutics to Underweight Rating From Equalweight, A..
MT
2021Jefferies Downgrades Adagio Therapeutics to Hold From Buy; Price Target is $10
MT
2021Morgan Stanley Downgrades Adagio Therapeutics to Equalweight from Overweight, Adjusts P..
MT
2021Guggenheim Downgrades Adagio Therapeutics to Neutral From Buy
MT
2021Stifel Downgrades Adagio Therapeutics to Hold From Buy, Adjusts Price Target to $9 From..
MT
2021--Morgan Stanley Upgrades Adagio Therapeutics to Overweight From Equalweight; Price Tar..
MT
2021Morgan Stanley Upgrades Adagio Therapeutics to Overweight From Equalweight; Price Targe..
MT
2021Analyst recommendations: AT&T, BancorpSouth Bank, CMO Group, Mag..
MS
2021Adagio Therapeutics : Morgan Stanley Starts Adagio Therapeutics at E..
MT
2021Adagio Therapeutics : Jefferies Starts Adagio Therapeutics at Buy Wi..
MT
2021Adagio Therapeutics : Stifel Starts Adagio Therapeutics at Buy With ..
MT
2021Adagio Therapeutics : Guggenheim Starts Adagio Therapeutics at Buy W..
MT
Upcoming event on INVIVYD, INC.